News

Jefferies Predicts Strong ETF Inflows in Second Half of 2024

Jefferies Predicts Strong ETF Inflows in Second Half of 2024

Outlook for Exchange-Traded Fund Inflows

Analysts at Jefferies are feeling optimistic about the potential for significant exchange-traded fund (ETF) inflows in the latter half of 2024. Building on the momentum seen in the first half of the year, they anticipate that this activity will continue to grow.

Current Inflow Trends

As of August, global ETF inflows have reached an impressive $809 billion, exceeding the six-year annual average of $752 billion. Historical data indicates that 57% of annual ETF flows typically occur in the second half of the year, suggesting an exciting influx on the horizon.

Historical Data and Projections

The analysts note that if historical trends hold, the second half is likely to outperform the first. Since 2010, the average increase in inflows during the second half compared to the first has been a notable 37%.

Growth of Active ETFs

Active ETFs are gaining popularity, with year-to-date inflows reaching $151 billion through July, which accounts for 29% of total industry inflows. These inflows are notably split, with fixed income making up 37% and equities 31%. This year is tracking significantly above the annual average of $34 billion since 2010.

Comparative Performance of Active and Passive ETFs

Focusing on the U.S. market, active ETFs have seen an average increase of 18% in the second half, while passive funds typically experience a remarkable 57% increase. This illustrates the evolving nature of the ETF landscape.

Insights on Market Concentration

Jefferies highlights the substantial concentration within the ETF market, where the top five firms manage about 84% of total ETF assets. Interestingly, while three of these leading firms have experienced declines in market share since 2010, BlackRock continues to be a major player.

Performance of Leading Firms

Despite holding the largest market share, BlackRock (NYSE: BLK) has seen its control drop from 45% to 31%. In contrast, Vanguard has increased its market share from 9% to 23%. Nonetheless, BlackRock has still managed to gather an impressive $220 billion in ETF flows year-to-date as of August.

Growth Potential in the International Market

The international ETF market offers even greater growth opportunities, as non-U.S. ETFs currently represent only 17% of total assets under management. In this arena, BlackRock commands a strong 32% market share, with Invesco following at 15%. This indicates that the international market could see further development in the coming years.

Frequently Asked Questions

What are the expectations for ETF inflows in 2024?

Jefferies anticipates strong ETF inflows in the second half of 2024, based on historical trends.

How much have global ETF inflows reached so far?

As of August, global ETF inflows have totaled $809 billion, surpassing the annual average.

What factors are contributing to the growth of active ETFs?

Active ETFs are gaining traction, attracting a significant share of inflows, particularly in fixed income and equities.

How concentrated is the ETF market?

The ETF market is highly concentrated, with the top five firms controlling approximately 84% of total assets under management.

What opportunities exist in the international ETF market?

There is considerable potential for growth in the international ETF market, where non-U.S. ETFs account for just 17% of assets under management.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigating Potential Breach of Duty by RxSight, Inc. Executives

Updated Category News Views 206

Overview of the Investigation into RxSight, Inc. Robbins LLP, a respected law firm specializing in shareholder rights, has initiated an investigation into potential breaches of fiduciary duties by the officers and directors of RxSight, Inc. This medical technology company, noted for its innovative light adjustable intraocular lenses used in cataract surgeries, is now...

Continue Reading
Man Group PLC Announces Stake in Deliveroo plc Holdings

Updated Category News Views 131

Man Group PLC's Public Disclosure on Deliveroo Holdings Recently, Man Group PLC has disclosed significant information regarding their holdings and interests in Deliveroo plc. This action reflects the increasing transparency required under financial regulations aimed at ensuring fair play in the market. Stakeholders and investors alike are keenly observing these...

Continue Reading
Synthetic Biology Market Growth Forecast: US$ 126.9 Billion by 2034

Updated Category News Views 76

Overview of the Synthetic Biology Market The global synthetic biology market is set for remarkable growth, with forecasts showing an increase from US$ 14.5 billion in 2024 to US$ 126.9 billion by 2034. This impressive growth represents a compound annual growth rate (CAGR) of 24.2% over the next decade, underscoring the growing significance of this field across various...

Continue Reading
Quantum Computing Investors: Join the Class Action Opportunity

Updated Category News Views 105

Significant Opportunity for Quantum Computing Investors Investors of Quantum Computing Inc. (NASDAQ: QUBT) should take note of an important opportunity to participate in a class action lawsuit aimed at addressing substantial losses. This lawsuit has been initiated by Bronstein, Gewirtz & Grossman LLC, a reputable law firm known for its expertise in investor protection....

Continue Reading
Important Fiserv Class Action Lawsuit Details You Should Know

Updated Category News Views 131

Understanding the Fiserv Class Action Lawsuit Investors in Fiserv, Inc. have significant details to grasp concerning an ongoing class action lawsuit. This legal action runs the course of securities fraud allegations that have raised concerns among stakeholders. The importance of timely action cannot be overstated as investors look to protect their interests. Allegations...

Continue Reading